Fig. 5From: 131I-Traced PLGA-Lipid Nanoparticles as Drug Delivery Carriers for the Targeted Chemotherapeutic Treatment of Melanoma a Cell viability of B16F10 cells after treatment with PL-131I and FA-PL-131I for 24 h. b Cell viabilities of B16F10 cells after incubation with different concentrations of free PTX, PLP-131I, and FA-PLP-131I for 24 hBack to article page